Pennsylvania 2025_0 Regular Session Status: In Committee Bipartisan · 11 D · 1 R cosponsors

HR 302 — A Resolution ensuring greater access to sickle cell disease treatments and designating the Department of Health to conduct a comprehensive and coordinated data collection effort to better understand and quantify the scope and impact of sickle cell disease on patients, communities and states throughout the United States.

Last action — Referred to HEALTH, Sept. 4, 2025

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the House. Introduced September 04, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the House.

Prognosis

Advancing 42% · moderate confidence

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

  • In Committee

    Current position in the legislative process.

  • 12 sponsors

    1 primary, 11 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (11 D · 1 R) — cross-party backing.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Summary

Promoting Greater Access and Research for Sickle Cell Disease

Bill Text

Action History

  1. Referred to HEALTH, Sept. 4, 2025

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 11 co-sponsors · 241 not signed on

Sponsors (1)

Co-sponsors (11)

Not signed on (241)

241 members have not signed on to this bill.

Show all 241 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HR 302 do?
Promoting Greater Access and Research for Sickle Cell Disease
Who sponsors HR 302?
HR 302 is sponsored by Ben Waxman (Democratic), Jeanne McNeill (Democratic), Greg Scott (Democratic), Jose Giral (Democratic), Patrick J. Harkins (Democratic), Carol Hill-Evans (Democratic), Benjamin V. Sanchez (Democratic), Johanny Cepeda-Freytiz (Democratic), La'Tasha D. Mayes (Democratic), Joseph C. Hohenstein (Democratic), Jill N. Cooper (Republican), and Dan K. Williams (Democratic).
What is the current status of HR 302?
This bill is in committee in the House. Introduced September 04, 2025. It must pass committee before a floor vote.
Where can I track HR 302?
Track HR 302 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HR 302

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HR 302

Last checked for changes 4 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →